Associated Papers
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial.
Peterschmitt MJ et al.
Journal of Parkinson's Disease, 2022
34897099 (PubMed )
Supplement: jpd-12-jpd212714-s001.pdf
The identification of eight novel glucocerebrosidase (GBA) mutations in patients with Gaucher disease.
Orvisky E et al.
Human Mutation, 2002
Hematologically important mutations: Gaucher disease.
Beutler E et al.
Blood Cells, Molecules & Diseases, 0
[Acute neuropathic (type 2) variant of Gaucher disease with mutation K198E].
Espinosa-García E et al.
Revista De Neurologia, 0
Select a paper to view details